Tigecycline PK in 8 to 11 year olds v1.0

• Research type

  Research Study

• Full title

  A Multicentre, Open-Label, ascending Multiple-Dose Study to Assess the Pharmacokinetics, Safety and Tolerability of Tigecycline in Patients 8 to 11 Years of Age with Selected Serious Infections.

• IRAS ID

  8333

• Contact name

  Adam Finn

• Contact email

  adam.finn@bristol.ac.uk

• Sponsor organisation

  Wyeth Research Division of Wyeth Pharmaceuticals

• Eudract number

  2007-002120-14

• Clinicaltrials.gov Identifier

  NCT00488345

• Research summary

  Research Summary not published at request of researcher

• REC name

  South West - Central Bristol Research Ethics Committee

• REC reference

  08/H0106/169

• Date of REC Opinion

  27 Feb 2009

• REC opinion

  Further Information Favourable Opinion